Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program Announces First Group of Physicians

Article

The Bristol Myers Squibb Foundation, together with its partners, National Medical Fellowships and the American Association for Cancer Research, has announced the first group of 52 physicians selected for its Diversity in Clinical Trials Career Development Program. The early-stage investigators are the first of 250 community-oriented clinical trialists who will be trained through the program by 2027.

The 52 physicians selected by an independent selection committee are an accomplished group working at a broad range of healthcare institutions in 22 states across the U.S. The physicians include 34 women and 18 men who represent a diverse cross section of races and ethnicities and bring a widely varied perspective and range of experiences to the program, as well as to their therapeutic focus areas of cancer (hematologic or solid tumors), immunologic disorders and cardiovascular diseases.

The first cohort of scholars will begin their two-year participation in October 2021 with a program orientation, followed in early November by a six-day intensive educational workshop on clinical research, called BMSF-AACR Design and Implementation of Clinical Trials Workshop.

More on the first physicians in the Diversity in Clinical Trials Career Development Program

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.